› 2020
Zubir Ahmed
Prophylaxis of Wound infections-antibiotics in Renal Donation (POWAR):
A UK Multicentre Double blind Placebo Controlled Randomised Trial
› 2019
Joint Winner
David Nasralla
A Randomized trial of normothermic preservation in liver transplantation
Dr Gemma Banham
Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial
› 2018
Chris Johnston
A structurally distinct TGF-beta mimic from an intestinal helminth parasite potently induces regulatory T cells
› 2017
Jason Ali
Diversity of the CD4 T Cell Alloresponse: The Short and the Long of It
› 2016
Jason Ali
CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection
› 2015
Michelle Willicombe
Postanastomic Transplant Renal Artery Stenosis: Association with De Nobo Class II Donor Specific Antibodies
› 2014
Kate Milward
Multiple Unit Pooled Umbilical Cord Blood is a Viable Source of Therapeutic Regulatory T Cells.
› 2013
Chris Callaghan
Regulation of Allograft survival by inhibitory FcgRllb signalling.
› 2012
Dominic Summers
Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK
› 2011
Joint Winner
Thet Su Win
Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production. Circulation: Heart Failure 2009 (2):361-9
Joanna Hester nee Wieckiewicz
In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells
› 2010
Yunchuan Ding
Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of Matrix Metalloproteinase -2 and -9.
› 2009
Manuela Gaspar
Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells.
› 2008
Kathryn Brown
› 2007
No Awards
› 2006
Peng H Tan
Imperial College, London
Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression.
› 2005
Mahzuz Karim
Nuffield Dept of Surgery, Oxford
Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process
› 2004
Nicola Monk
Deptartment of Nephrology and Transplantation Guy’s Hospital, London.
Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade